(Q38016566)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672330%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672330%20AND%20SRC:MED&resulttype=core&format=json

metabolic dysfunction–associated steatotic liver disease

3 February 2020

main subject

fatty liver disease

0 references

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672330%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

C D Byrne

series ordinal

1

1 reference

27 August 2017

1 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672330%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672330%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672330%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672330%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

1098-1107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672330%20AND%20SRC:MED&resulttype=core&format=json

Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Metabolic disturbances in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Hepatic fatty acid partitioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Decreased non-esterified fatty acid suppression and features of the insulin resistance syndrome occur in a sub-group of individuals with normal glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

The metabolic syndrome: common origins of a multifactorial disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Serum markers detect the presence of liver fibrosis: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Body mass index and waist circumference in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Current treatment of non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

The role of non-alcoholic fatty liver disease in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Carotid lesions in outpatients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Narrative review: hepatobiliary disease in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Ezetimibe as a potential treatment for non-alcoholic fatty liver disease: is the intestine a modulator of hepatic insulin sensitivity and hepatic fat accumulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

The relationship between the fatty acid composition of immune cells and their function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

A systemic review of the roles of n-3 fatty acids in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Understanding omega-3 polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Fatty liver: a novel component of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X

Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03732.X